Synthesis and Preclinical Evaluation of a Novel FAPI-04 Dimer for Cancer Theranostics-Reference-Cited by-同舟云学术

Synthesis and Preclinical Evaluation of a Novel FAPI-04 Dimer for Cancer Theranostics

Author:

Zhong Xuan¹²,Guo Jingru³,Han Xiuping⁴,Wu Wenyu⁴,Yang Rui⁴,Zhang Jun¹²^ORCID,Shao Guoqiang⁴

Affiliation:

1. Nanjing University of Chinese Medicine, Nanjing 210046, China

2. Department of Nuclear Medicine, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou 225300, China

3. Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing 210009, China

4. Department of Nuclear Medicine, Nanjing Medical University Affiliated Nanjing Hospital, Nanjing 210029, China

Funder

Jiangsu Provincial Medical Youth Talent

Taizhou Municipal Science and Technology Bureau

Six Talent Peaks Project in Jiangsu Province

Nanjing Medical Science and Technique Development Foundation

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

Reference35 articles.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

5. Clinical translation of a novel FAPI dimer [68Ga]Ga-LNC1013;European Journal of Nuclear Medicine and Molecular Imaging;2024-04-02